Table 1.
The correlation between TRIM50 mRNA expression and the patients' clinical pathology data
| Characteristic | Overall | Expression of TRIM50 | p | |
|---|---|---|---|---|
| High | Low | |||
| N | 124 | 62 | 62 | |
| Age, year | 64.92 ± 11.70 | 63.53 ± 12.38 | 66.31 ± 10.91 | 0.188 |
| Gender, n (%) | 0.208 | |||
| Female | 59 (47.6%) | 26 (21.0%) | 33 (26.6%) | |
| Male | 65 (52.4%) | 36 (29.0%) | 29 (23.4%) | |
| Tumor volume, cm3 | 17.86 (13.64, 26.76) | 15.75 (13.13, 20.30) | 23.65 (14.11, 29.13) | 0.002 |
| T classification, n (%) | 0.170 | |||
| I | 8 (6.5%) | 6 (4.8%) | 2 (1.6%) | |
| II | 21 (16.9%) | 12 (9.7%) | 9 (7.3%) | |
| III | 40 (32.3%) | 22 (17.7%) | 18 (14.5%) | |
| IV | 55 (44.4%) | 22 (17.7%) | 33 (26.6%) | |
| N classification, n (%) | 0.407 | |||
| 0 | 25 (20.2%) | 16 (12.9%) | 9 (7.3%) | |
| 1 | 25 (20.2%) | 12 (9.7%) | 13 (10.5%) | |
| 2 | 40 (32.3%) | 17 (13.7%) | 23 (18.5%) | |
| 3 | 34 (27.4%) | 17 (13.7%) | 17 (13.7%) | |
| M classification, n (%) | 0.011 | |||
| 0 | 116 (93.5%) | 62 (50.0%) | 54 (43.5%) | |
| 1 | 8* (6.5%) | 0 (0%) | 8* (6.5%) | |
| Pathologic stage, n (%) | 0.011 | |||
| I | 12 (9.7%) | 8 (6.5%) | 4 (3.2%) | |
| II | 40 (32.3%) | 24 (19.4%) | 16 (12.9%) | |
| III | 64 (51.6%) | 30 (24.2%) | 34 (27.4%) | |
| IV | 8* (6.5%) | 0 (0%) | 8* (6.5%) | |
| OS, month | 18.93 (12.02, 34.24) | 28.05 (13.38, 36.92) | 14.30 (10.42, 32.12) | 0.004 |
“*” denotes patients with resectable single distant metastasis. Bold values indicate an intergroup p <0.05, indicating the presence of a statistically significant difference.